BUZZ-Grifols hits bottom of IBEX on weak 2026 revenue growth outlook

Reuters02-27 17:24
BUZZ-Grifols hits bottom of IBEX on weak 2026 revenue growth outlook

** Healthcare company Grifols GRLS.MC sinks to the bottom of IBEX 35 index, shares falling about 6% after 2025 full-year results, as it fails to deliver a promising outlook for revenue growth in 2026

** The company did not provide specific revenue guidance as it will now focus on margins, cash flow and deleveraging, but added it expects moderate growth at constant exchange rates for 2026

** J.P. Morgan says a downgrade to 2026 EBITDA and the slowdown in underlying revenue growth are reasons for the shares falling

** The broker sees slower revenue growth as Grifols is moving from volume-driven growth to margin-driven growth

** The company's shares are on track for its worst day since April 2025

(Reporting by Gemma Guasch)

((Gemma.guasch@thomsonreuters.com ;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment